Unnamed sources told Reuters that AbbVie is working with Morgan Stanley to auction off the portfolio in order to pay off debt and focus on new areas, according to Endpoints News. The portfolio includes the Lo Loestrin Fe birth control pill.
CVC Capital Partners, a private equity firm, is reportedly looking to purchase the women’s health portfolio for its portfolio company, Theramex.
Allergan tried to sell the unit in 2018, but scrapped plans several months before the AbbVie acquisition was finalized, Endpoints News reported.
A spokesperson for AbbVie told Endpoints News: “We don’t comment on rumors.”
Read the full article here.
More articles on pharmacy:
New York City pharmacist starts pop-up COVID-19 vaccination sites
Moderna studying COVID-19 vaccine’s use in children, refrigerator-safe vaccine
CDC: Most people return for second COVID-19 vaccine dose
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
